青年中文青年中文

carbohydrate antigen的意思

carbohydrate antigen中文翻譯:

糖抗原

相似詞語短語

carbohydrate───n.[有化]碳水化合物;[有化]糖類

carbohydrate metabolism───碳水化合物代謝

carbohydrate definition───碳水化合物定義

carbohydrate molecule───碳水化合物分子

carbohydrate foods───碳水化合物食品

carbohydrate monomer───碳水化合物單體

carbohydrate structure───碳水化合物結構

chimeric antigen receptor───嵌合抗原受體(一種細胞治療技術)

consistent carbohydrate diet───持續碳水化合物飲食

雙語使用場景

Objective To study on expression and clinical application of serum carbohydrate antigen CA50 of patients with colorectal cancer.───目的研究大腸癌患者血清糖鏈抗原c A50表達水平及其臨床意義。

Objective To explore the diagnostic values of serum carbohydrate antigen CA242, CA125 and CA199 in GI tumors.───目的探討血清中CA242、CA125、CA199含量對消化系腫瘤中的診斷價值。

Objective To highlight the characteristics of Idiopathic pulmonary fibrosis(IPF) with marked elevated serum carbohydrate antigen sialyl Lewis(a)(CA19-9).───目的提高對CA19 9顯著升高的特發性肺纖維化(IPF)的認識,評價CA19 9的升高與IPF進展的相關性。

Aim: To investigate the diagnostic value of serum carbohydrate antigen 19-9 (CA19-9) in benign or malignant diseases of biliary tract.───目的:探討血清糖類抗原CA19-9對良、惡性膽道疾病的診斷價值。

Objective To study on expression and clinical application of serum carbohydrate antigen CA50 of patients with colorectal cancer.───目的研究大腸癌患者血清糖鏈抗原CA50表達水平及其臨床意義。

Objective To study the value of carbohydrate antigen 125 (CA125) level measurement in diagnosis and treatment of tubercular peritonitis.───目的了解和評價CA125檢測對結核性腹膜炎的診斷和治療價值。

carbohydrate antigen 199; chemiluminescence; domestic product; imported product;───糖類抗原199;化學發光;國產產品;進口產品;評價。

Evaluation of monitoring the half-life of carbohydrate antigen CA19-9 in primary hepatocellular carcinoma with metastasis───糖類抗原19-9生物半衰期監測原發性肝癌轉移的評價

Analysis of the clinical value of carbohydrate antigen 125 with multiple tumor markers protein biochip detective system───多腫瘤標志物蛋白芯片檢測糖鏈抗原125的臨床價值分析

英語使用場景

This study provided a precursor of N-propionyl-D-mannosamine for the tumor-associated carbohydrate antigen.

Objective To investigate the diagnostic value of serum carbohydrate antigen 125 ( CA 125 ) in liver carcinoma and hepatocirrhosis.